What is Instant Systems?
Instant Systems is a specialized provider of innovative single-use supplies crucial for healthcare, tissue banking, and cell and gene therapy manufacturing. Their comprehensive product portfolio encompasses essential items such as cell culture systems, centrifuge tubes, and a variety of freezing and storage solutions. The company is dedicated to empowering scientists, technicians, researchers, and health professionals by delivering reliable tools that enhance the integrity and delivery of biologics. Their target clientele includes hospitals, manufacturers, and organizations operating within the regenerative medicine and tissue banking sectors.
How much funding has Instant Systems raised?
Instant Systems has raised a total of $781K across 2 funding rounds:
Debt
$350K
Debt
$431K
Debt (2020): $350K with participation from PPP
Debt (2021): $431K led by PPP
What's next for Instant Systems?
The recent major strategic investment signals a new phase of expansion and development for Instant Systems. With a substantial capital infusion, the company is poised to scale its operations, further innovate its product lines, and potentially broaden its market reach within the rapidly growing fields of cell and gene therapy and regenerative medicine. This strategic backing is expected to accelerate the company's mission to improve patient outcomes through advanced manufacturing solutions.
See full Instant Systems company page
